Using natural language processing to characterize and predict homeopathic product-associated adverse events in consumer reviews: comparison to reports to FDA Adverse Event Reporting System (FAERS)

被引:4
|
作者
Konkel, Karen [1 ,2 ,5 ]
Oner, Nurettin [2 ]
Ahmed, Abdulaziz [2 ]
Jones, S. Christopher [1 ]
Berner, Eta S. [2 ,3 ]
Zengul, Ferhat D. [2 ,3 ,4 ]
机构
[1] US FDA, Ctr Drug Evaluat & Res, Div Pharmacovigilance, Off Surveillance & Epidemiol, Silver Spring, MD 20993 USA
[2] Univ Alabama Birmingham, Sch Hlth Profess, Dept Hlth Serv Adm, Birmingham, AL 35233 USA
[3] Univ Alabama Birmingham, Informat Inst, Birmingham, AL 35294 USA
[4] Univ Alabama Birmingham, Ctr Integrated Syst, Elect & Comp Engn, Birmingham, AL 35294 USA
[5] US FDA, 10903,New Hampshire Ave, Silver Spring, MD 20993 USA
关键词
natural language processing; drug safety; adverse drug event; homeopathic remedies; OTC drugs; consumer preferences;
D O I
10.1093/jamia/ocad197
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
Objective: Apply natural language processing (NLP) to Amazon consumer reviews to identify adverse events (AEs) associated with unapproved over the counter (OTC) homeopathic drugs and compare findings with reports to the US Food and Drug Administration Adverse Event Reporting System (FAERS).Materials and methods: Data were extracted from publicly available Amazon reviews and analyzed using JMP 16 Pro Text Explorer. Topic modeling identified themes. Sentiment analysis (SA) explored consumer perceptions. A machine learning model optimized prediction of AEs in reviews. Reports for the same time interval and product class were obtained from the FAERS public dashboard and analyzed.Results: Homeopathic cough/cold products were the largest category common to both data sources (Amazon = 616, FAERS = 445) and were analyzed further. Oral symptoms and unpleasant taste were described in both datasets. Amazon reviews describing an AE had lower Amazon ratings (X-2 = 224.28, P < .0001). The optimal model for predicting AEs was Neural Boosted 5-fold combining topic modeling and Amazon ratings as predictors (mean AUC = 0.927).Discussion: Topic modeling and SA of Amazon reviews provided information about consumers' perceptions and opinions of homeopathic OTC cough and cold products. Amazon ratings appear to be a good indicator of the presence or absence of AEs, and identified events were similar to FAERS.Conclusion: Amazon reviews may complement traditional data sources to identify AEs associated with unapproved OTC homeopathic products. This study is the first to use NLP in this context and lays the groundwork for future larger scale efforts.
引用
收藏
页码:70 / 78
页数:9
相关论文
共 50 条
  • [21] Adverse events associated with carbamazepine: a pharmacovigilance study using the FDA Adverse Event Reporting System
    Huang, Shulan
    Dong, Hanlin
    Luo, Dongqiang
    Jiang, Jiazhen
    Liu, Manting
    Wu, Jiayu
    Dou, Xiangyun
    Zhou, Siyuan
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [22] Gabapentinoid abuse, suicide and behavior related adverse event reports: Data mining within FDA adverse events reporting system (FAERS)
    Elsobky, Yasmin
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2020, 105
  • [23] ADVERSE EVENTS ASSOCIATED WITH ANTIOBESITY MEDICATION USE: ANALYSIS OF THE FDA ADVERSE EVENT REPORTING SYSTEM FAERS 1997-2015
    Yue, X.
    Xia, Y.
    Guo, J. J.
    VALUE IN HEALTH, 2016, 19 (03) : A241 - A241
  • [24] Pharmacosurvellience Study of FDA Adverse Event Reporting System (FAERS) Events of Tofacitinib and Upadacitinib
    Barlas, Nur
    Barlas, Sait
    Milutinovic, Stefan
    Basnyat, Shristi
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 2058 - 2059
  • [25] Ocular adverse events associated with anti-VEGF therapy: A pharmacovigilance study of the FDA adverse event reporting system (FAERS)
    Ma, Pan
    Pan, Xinmei
    Liu, Ruixiang
    Qu, Ya
    Xie, Linli
    Xie, Jiangchuan
    Cao, Liya
    Chen, Yongchuan
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [26] Bleeding related adverse events associated with antiviral treatment in influenza patients: A disproportionality analysis using FDA adverse event reporting system (FAERS)
    Sarker, Jyotirmoy
    Carkovic, Emir
    Lee, Todd A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 486 - 487
  • [27] A Review of Dental Adverse Events Using the FDA Adverse Event Reporting System
    Altman, Keith
    Budny, Renata
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 400 - 400
  • [28] Pharmacosurveillance study of FDA Adverse Event Reporting System (FAERS) events of Tirzepatide and Semaglutide
    Logvinsky, Ilana
    Barlas, Sait
    Maddineni, Gautam
    Wood, Malissa
    Delibasic, Maja
    CIRCULATION, 2024, 150
  • [29] POST-MARKETING ADVERSE EVENTS (AES) ASSOCIATED WITH TETRABENAZINE (TBZ): FINDINGS USING FDA'S ADVERSE EVENT REPORTING SYSTEM (FAERS)
    Claassen, Daniel O.
    Iyer, Ravi
    Dimbil, Mo
    Giron, Abril
    De Boer, Lisa
    Gandhi, Sanjay
    Hoffman, Keith B.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2016, 87 : A73 - A73
  • [30] Comparison of adverse reaction reports for rivastigmine, and donepezil using the FDA's Adverse Event Reporting System
    Rizzo, JA
    Chang, SB
    Cohen, A
    ANNALS OF NEUROLOGY, 2001, 50 (03) : S76 - S76